NED Biosystems
NED Biosystems is dedicated to developing safe, efficacious, and comprehensive systems treatments for complex diseases, starting with cancer and infectious diseases. They employ a systems-based approach that targets the behavior of entire biological systems rather than individual components, aiming to provide therapies that lack traditional toxicity and side effects. Their mission is to enable patients worldwide to achieve and sustain 'No Evidence of Disease' through innovative, safe, and effective treatments.
Industries
Nr. of Employees
small (1-50)
NED Biosystems
245 First Street, Riverview II, 18th Fl, Cambridge, MA 02142
Patents
Products
Patented systems-based oral cancer treatment (composition and method of use)
A systems-methodology oral therapeutic protocol designed to target multiple cancer-driving processes using repurposed agents at doses intended to limit customary toxicity; described as protected by issued patent(s).
Systems-based oral antiviral treatment (development-stage)
An oral systems-methodology therapeutic protocol being developed for broad-spectrum respiratory and other viral infections; described as a second systems treatment in development.
Patented systems-based oral cancer treatment (composition and method of use)
A systems-methodology oral therapeutic protocol designed to target multiple cancer-driving processes using repurposed agents at doses intended to limit customary toxicity; described as protected by issued patent(s).
Systems-based oral antiviral treatment (development-stage)
An oral systems-methodology therapeutic protocol being developed for broad-spectrum respiratory and other viral infections; described as a second systems treatment in development.
Services
Partnerships with academic and research institutes to design and execute translational studies that apply systems-based methodologies to clinical development.
Clinical operations and program management for early- and late-phase studies including protocol implementation, site coordination and medical monitoring.
Partnerships with academic and research institutes to design and execute translational studies that apply systems-based methodologies to clinical development.
Clinical operations and program management for early- and late-phase studies including protocol implementation, site coordination and medical monitoring.
Expertise Areas
- Systems-based therapeutic development
- Oncology therapeutics and translational oncology
- Antiviral therapeutic development
- Clinical trial management and biomarker strategy
Key Technologies
- Systems biology
- Drug repurposing
- Oral combination therapy protocols
- Proteomics and biomarker discovery